Aleve Challenge, New Study Catch Up To Advil 'Works Longer' Claim In NAD Review

Although 1993 studies to make Aleve available OTC didn't support claiming the naproxen oral analgesic lasted longer than ibuprofen-containing Advil, 2018 study Bayer submitted for National Advertising Division review shows Advil's efficacy doesn't exceed Aleve's. Report also says while Pfizer criticized inpatient methodology of Bayer's study, inpatient is industry standard method for pain medication trials.

Truth in Advertising Price Tag Honest Business 3d Render Illustration - Illustration

Evidence that supports making a drug available OTC in the US isn't the final word on marketing claims for the ingredient, a Council of Better Bureaus' industry self-regulation arm concluded in a review of Aleve marketer Bayer AG's challenge to Pfizer Inc.'s advertising for Advil.

A report published 10 September by the National Advertising Division of the council's BBB National Programs Inc. also states that...